Established Norms of Covid’19 Management During the Recovery and Stabilization Phase: Perspectives on The Efficiency of Nanotechnology

Introduction Coronavirus disease 2019 (COVID‑19) is caused by the virus SARS‑CoV‑2 and was first reported in China in late 2019. [1] The infection rapidly spread worldwide and was declared a…

Continue ReadingEstablished Norms of Covid’19 Management During the Recovery and Stabilization Phase: Perspectives on The Efficiency of Nanotechnology

Evolving insights into Nanotechnology Competence: Emerging Benchmarks in the Post-Pandemic Transition of Covid-19

Introduction: The COVID-19 occurrence, initially recognised in Wuhan, China in late 2019, swiftly escalated into solitary of the most significant world-wide health predicaments since the 1918 influenza pandemic. Its rapid…

Continue ReadingEvolving insights into Nanotechnology Competence: Emerging Benchmarks in the Post-Pandemic Transition of Covid-19

Emerging Therapeutic Targets in Immune and Inflammatory Disorders: Advances Beyond Conventional Receptors

Introduction Immune and inflammatory disorders comprise a broad group of conditions characterized by dysregulated immune responses that lead to chronic tissue damage, impaired organ function, and long-term health complications. These…

Continue ReadingEmerging Therapeutic Targets in Immune and Inflammatory Disorders: Advances Beyond Conventional Receptors